20
Sep 2020

HeartForce Selected as Top 5 Company and Reaches Final Stage of G4A Partnerships Program with Bayer

HeartForce is proud to have been selected as a top 5 company for “Patient Monitoring” by Bayer and has been invited to participate in the company’s 2020 Cardiovascular Growth Challenge.

HeartForce was selected as one of the  finalists from  who participated in the Bayer AG Deutschland G4A Partnership program. The G4A Partnership Program offers leading healthtech companies opportunities to partner with Bayer on integrated healthcare solutions in the digital health space. 

The partnership will allow HeartForce to tap into Bayer’s global presence and business acumen to drive accelerated change in the healthcare industry through direct collaboration.

Back to News